SCHEMBL19685701

SCHEMBL19685701

O=C1CCCc2ccc(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
MAOA P21397 3/20 0.42
MAOB P27338 3/20 0.42
CYP2A6 P11509 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HSD17B1 P14061 1/20 0.41
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
MAPT P10636 1/20 0.37
GRM5 P41594 1/20 0.36
TYRO3 Q06418 1/20 0.36
NTRK2 Q16620 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685907 0.90 HSD17B1 (0.50) LMNAMAOAMAOBCYP2A6SMN1; SMN2
SCHEMBL19685699 0.86 MAOA (0.45) LMNAMAOAMAOBCYP2A6SMN1; SMN2
SCHEMBL19685811 0.82 EDNRB (0.37) LMNAMAOBSMN1; SMN2HPGDMEN1
SCHEMBL19685700 0.82 MAOA (0.39) LMNAMAOAMAOBCYP2A6SMN1; SMN2
SCHEMBL29395799 0.81 MAOA (0.58) LMNAMAOAMAOBCYP2A6SMN1; SMN2
SCHEMBL5211178 0.81 MAOA (0.58) LMNAMAOAMAOBCYP2A6SMN1; SMN2
SCHEMBL19685759 0.80 MAOB (0.43) LMNAMAOAMAOBALDH1A1MAPT
SCHEMBL25565473 0.78 KDM4E (0.41) SMN1; SMN2MEN1ALDH1A1KMT2AHTT
SCHEMBL15613804 0.77 PARP10 (0.40) LMNASMN1; SMN2HSD17B1MEN1KMT2A
SCHEMBL19685998 0.77 SDCBP (0.40) MAOBTYRO3NTRK2CLK4DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS LMNA 3026/4885MAOA 1632/4885MAOB 1878/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS LMNA 3026/4885MAOA 1632/4885MAOB 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.